Providers and patients fish for that delicate balance between access and abandonment.
An answer to your question: What does the Part D coverage gap do to drug sales?
Dual eligibles have less access to top brands than they did before
the launch of Part D
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial